Nektar Therapeutics
Price & Volume
Stats
See moreOpen | $66.46 |
Previous Close | $65.90 |
Day Range | $65.10-$69.17 |
52W Range | $6.48-$75.67 |
Market Cap | $1.8B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $62.6M |
Revenue Growth (YoY) | -51.1% |
Gross Profit (12 Mos) | $54.6M |
Diluted EPS | -$9.83 |
News
See moreYahoo Finance • 8 days ago
Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight
Yahoo Finance • 17 days ago
Nektar eyes late-stage program for eczema therapy after positive mid-stage data
Yahoo Finance • 2 months ago
Wall Street Futures Decline Premarket Tuesday Pending Key US Economic Data, Delayed Jobs Report
Yahoo Finance • 3 months ago
Autodesk upgraded, Nio downgraded: Wall Street's top analyst calls
About
CEO | Mr. Howard W. Robin |
CFO | Ms. Sandra A. Gardiner |
Address | 455 Mission Bay Boulevard South, San Francisco, CA, United States, 94158 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 61 |
